Cellectis Sa Stock Buy Hold or Sell Recommendation
| CMVLF Stock | USD 2.54 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Cellectis SA is 'Strong Hold'. Macroaxis provides Cellectis buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CMVLF positions.
Check out Cellectis Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Cellectis and provide practical buy, sell, or hold advice based on investors' constraints. Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Cellectis |
Execute Cellectis Buy or Sell Advice
The Cellectis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cellectis SA. Macroaxis does not own or have any residual interests in Cellectis SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cellectis' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Cellectis Trading Alerts and Improvement Suggestions
| Cellectis SA generated a negative expected return over the last 90 days | |
| The company reported the revenue of 57.29 M. Net Loss for the year was (114.2 M) with profit before overhead, payroll, taxes, and interest of 34.18 M. | |
| Cellectis SA has accumulated about 153.13 M in cash with (104.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Cellectis current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cellectis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cellectis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Cellectis Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cellectis or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cellectis' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cellectis pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Cellectis Volatility Alert
At this time Cellectis SA exhibits very low volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cellectis' pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cellectis' pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Cellectis Fundamentals Vs Peers
Comparing Cellectis' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cellectis' direct or indirect competition across all of the common fundamentals between Cellectis and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cellectis or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Cellectis' fundamental indicators could also be used in its relative valuation, which is a method of valuing Cellectis by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cellectis to competition |
| Fundamentals | Cellectis | Peer Average |
| Return On Equity | -0.56 | -0.31 |
| Return On Asset | -0.24 | -0.14 |
| Operating Margin | (6.01) % | (5.51) % |
| Current Valuation | 82.79 M | 16.62 B |
| Shares Outstanding | 55.59 M | 571.82 M |
| Shares Owned By Institutions | 9.80 % | 39.21 % |
| Price To Earning | (13.64) X | 28.72 X |
| Price To Book | 0.79 X | 9.51 X |
| Price To Sales | 4.79 X | 11.42 X |
| Revenue | 57.29 M | 9.43 B |
| Gross Profit | 34.18 M | 27.38 B |
| EBITDA | (103.2 M) | 3.9 B |
| Net Income | (114.2 M) | 570.98 M |
| Cash And Equivalents | 153.13 M | 2.7 B |
| Cash Per Share | 3.37 X | 5.01 X |
| Total Debt | 18.77 M | 5.32 B |
| Debt To Equity | 0.52 % | 48.70 % |
| Current Ratio | 3.17 X | 2.16 X |
| Book Value Per Share | 3.00 X | 1.93 K |
| Cash Flow From Operations | (104.56 M) | 971.22 M |
| Earnings Per Share | (2.95) X | 3.12 X |
| Number Of Employees | 294 | 18.84 K |
| Beta | 2.0 | -0.15 |
| Market Capitalization | 131.39 M | 19.03 B |
| Total Asset | 382.08 M | 29.47 B |
| Retained Earnings | (206 M) | 9.33 B |
| Working Capital | 239 M | 1.48 B |
| Current Asset | 297 M | 9.34 B |
| Current Liabilities | 58 M | 7.9 B |
| Z Score | 4.2 | 8.72 |
| Net Asset | 382.08 M |
Cellectis Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cellectis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cellectis Buy or Sell Advice
When is the right time to buy or sell Cellectis SA? Buying financial instruments such as Cellectis Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cellectis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Marketing Thematic Idea Now
Marketing
Companies providing marketing and public relation (PR) services as well as news and media distribution. The Marketing theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marketing Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in Cellectis Pink Sheet
When determining whether Cellectis SA is a strong investment it is important to analyze Cellectis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cellectis' future performance. For an informed investment choice regarding Cellectis Pink Sheet, refer to the following important reports:Check out Cellectis Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.